ERBB2 and colorectal carcinoma: CRC has been considered a successful model for the determination of genetic biomarkers in oncology such as KRAS, NRAS, BRAF mutations, HER2 amplification, and microsatellite instability high (MSI-H) or mismatch repair deficiency (dMMR) [1,9].